NEUVIPDA

View On IC.GC.CA

SEARCHED

on 18 Mar 2025

Last Applicant/ Owned by

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89B-1330 Rixensart

Serial Number

2302438 filed on 7^th Dec 2023

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

K1P1J9

NEUVIPDA

Trademark usage description

pharmaceutical and medicinal preparations and substances; vaccines.

Classification Information

2302438

Trademark

Action Taken	Status
Submitted for opposition 48 on 24^th Mar 2025	Agent Changed
Submitted for opposition 22 on 18^th Mar 2025	Search Recorded
Submitted for opposition 20 on 18^th Mar 2025	Examiner's First Report
Submitted for opposition 223 on 18^th Mar 2025	Total Provisional Refusal
Submitted for opposition 256 on 28^th Oct 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 28^th Dec 2023	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 28^th Dec 2023	Created
Submitted for opposition 31 on 28^th Dec 2023	Formalized
Submitted for opposition 228 on 7^th Dec 2023	International Registration
Submitted for opposition 30 on 7^th Dec 2023	Filed